Industry litigation – Page 4
-
BusinessJ&J proposes to pay nearly $9 billion to settle talc lawsuits
Company re-files for bankruptcy of a subsidiary in the hopes of resolving tens of thousands of claims its products caused cancer
-
BusinessNew Jersey sues Dow Chemical and others over 1,4-dioxane pollution
US State wants companies to be held accountable for cleaning up widespread contamination
-
BusinessFragrance firms face coordinated cartel probe
Givaudan, Firmenich, Symrise and IFF raided by competition authorities
-
BusinessUS government sues chemical firm over chloroprene emissions
Denka disputes claims of ‘unacceptably high’ releases from neoprene manufacturing facility
-
BusinessContaminated cough syrups death toll passes 300 in four months
Deadly glycol contamination discovered in Uzbekistan, following cases in The Gambia and Indonesia
-
BusinessJ&J subsidiary claims key talc research is fraudulent
Complaint alleges study that helped link talc to cancer contained false information
-
NewsUS chemist Feng Tao avoids prison sentence for hiding ties to China
Judge’s ruling that professor did not harm his university or funding agency has crushed the government’s case
-
Business3M pledges to exit PFAS manufacturing
Conglomerate will remove fluorochemicals from portfolio in a bid to stay ahead of rapidly tightening regulations
-
BusinessChemicals industry roundup 2022
Russia’s invation of Ukraine mounted further pressure onto already strained supply chains
-
BusinessJudge dismisses ranitidine lawsuits over lack of evidence
Drug degrades to produce nitrosamines, but the judge ruled the link between this and plaintiffs’ cancers could not be proven
-
BusinessTheranos leaders to be imprisoned for blood testing fraud
Sunny Balwani and Elizabeth Holmes will both serve more than 10 years
-
BusinessUS government intervenes to avert rail strike
Congress enforces a contract deal to prevent a national rail shutdown that would effectively halt chemicals production
-
OpinionElizabeth Holmes to be imprisoned for Theranos fraud
Blood testing company founder’s 11-year sentence should serve as a warning to investors
-
BusinessEurope gears up for streamlined patent system
Delayed Unified Patent Court set to begin operating in April
-
BusinessArrayit chief convicted of fraud over blood testing
Mark Schena misrepresented the company’s value to investors and defrauded public and private insurers
-
BusinessNature-inspired crop protection
Plant extracts, proteins and pheromones aiming to replace conventional chemical pesticides
-
OpinionConfusing cannabinoids
Decomposition during GC–MS analysis can thwart efforts to determine if a product is legal
-
BusinessChemours sues over US PFAS safety limit
Fluoropolymer maker appeals new safety standard for GenX, calling it ‘scientifically unsound’
-
BusinessSecond Theranos executive convicted of fraud
Blood testing startup president Ramesh ‘Sunny’ Balwani defrauded both investors and patients
-
BusinessUS reinstates Superfund taxes to clean up 1300 contaminated sites
Levy on 42 chemicals and their derivatives aims to revive neglected cleanup programme